New England Research & Management, Inc. Medtronic PLC Transaction History

New England Research & Management, Inc.

$213 Million
Q3 2024

A detailed history of New England Research & Management, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, New England Research & Management, Inc. holds 14,527 shares of MDT stock, worth $1.18 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

14,527

Previous 16,037 9.42%

Holding current value

$1.18 Million

Previous $1.26 Million 3.65%

% of portfolio

0.61%

Previous 0.61%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$76.84 - $91.03 $116,028 - $137,455	-1,510 Reduced 9.42%	14,527 $1.31 Million
Q2 2024 Jul 09, 2024	SELL	$78.71 - $87.02 $166,235 - $183,786	-2,112 Reduced 11.64%	16,037 $1.26 Million
Q1 2024 Apr 16, 2024	BUY	$82.84 - $88.09 $9,526 - $10,130	115 Added 0.64%	18,149 $1.58 Million
Q4 2023 Feb 06, 2024	SELL	$69.43 - $83.43 $32,632 - $39,212	-470 Reduced 2.54%	18,034 $1.49 Million
Q3 2023 Oct 10, 2023	SELL	$78.22 - $90.4 $35,199 - $40,680	-450 Reduced 2.37%	18,504 $1.45 Million
Q2 2023 Jul 05, 2023	BUY	$79.47 - $91.38 $197,085 - $226,622	2,480 Added 15.05%	18,954 $1.67 Million
Q1 2023 Apr 06, 2023	BUY	$76.72 - $87.58 $245,964 - $280,781	3,206 Added 24.16%	16,474 $1.33 Million
Q4 2022 Jan 09, 2023	SELL	$76.18 - $87.74 $426,303 - $490,993	-5,596 Reduced 29.66%	13,268 $1.03 Million
Q3 2022 Oct 06, 2022	SELL	$80.75 - $95.31 $18,976 - $22,397	-235 Reduced 1.23%	18,864 $1.52 Million
Q2 2022 Jul 20, 2022	BUY	$87.4 - $113.09 $306,074 - $396,041	3,502 Added 22.45%	19,099 $1.71 Million
Q1 2022 Apr 20, 2022	BUY	$100.58 - $112.38 $173,802 - $194,192	1,728 Added 12.46%	15,597 $1.73 Million
Q4 2021 Jan 05, 2022	BUY	$99.53 - $127.75 $572,297 - $734,562	5,750 Added 70.82%	13,869 $1.44 Million
Q1 2021 Apr 16, 2021	BUY	$111.18 - $119.74 $2,779 - $2,993	25 Added 0.31%	8,119 $959,000
Q4 2020 Jan 07, 2021	SELL	$100.57 - $117.14 $45,256 - $52,713	-450 Reduced 5.27%	8,094 $948,000
Q3 2020 Oct 08, 2020	SELL	$90.13 - $108.78 $3,334 - $4,024	-37 Reduced 0.43%	8,544 $888,000
Q1 2020 Jun 15, 2020	BUY	$72.92 - $121.3 $97,056 - $161,450	1,331 Added 18.36%	8,581 $774,000
Q3 2019 Nov 04, 2019	SELL	$98.02 - $111.18 $53,911 - $61,149	-550 Reduced 7.05%	7,250 $787,000
Q2 2019 Jul 09, 2019	SELL	$84.15 - $99.38 $134,640 - $159,008	-1,600 Reduced 17.02%	7,800 $760,000
Q1 2019 Apr 03, 2019	BUY	$82.45 - $93.79 $30,918 - $35,171	375 Added 4.16%	9,400 $856,000
Q4 2018 Jan 11, 2019	BUY	$85.8 - $99.49 $774,345 - $897,897	9,025 New	9,025 $821,000
Q2 2018 Jul 05, 2018	SELL	$77.48 - $87.83 $1.03 Million - $1.17 Million	-13,325 Closed	0 $0
Q1 2018 Apr 17, 2018	SELL	$76.55 - $87.26 $168,639 - $192,233	-2,203 Reduced 14.19%	13,325 $1.07 Million
Q4 2017 Jan 09, 2018	SELL	$76.93 - $83.5 $127,242 - $138,109	-1,654 Reduced 9.63%	15,528 $1.25 Million
Q3 2017 Oct 25, 2017	BUY	$77.71 - $84.6 $1.34 Million - $1.45 Million	17,182	17,182 $1.34 Million

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account

New England Research & Management, Inc. Medtronic PLC Transaction History